Tag «RQ-00000004»

Tegoprazan

It’s only fair to share…   Tegoprazan RN: 942195-55-3 UNII: W017G7IF4S ROTATION (-) Molecular Formula, C20-H19-F2-N3-O3, Molecular Weight, 387.3841 (S)-4-(5,7-difluorochroman-4-yloxy)-N,N,2-trimethyl-lH-benzo[d]imidazole-6-carboxamide). 1H-Benzimidazole-5-carboxamide, 7-(((4S)-5,7-difluoro-3,4-dihydro-2H-1-benzopyran-4-yl)oxy)-N,N,2-trimethyl- 7-(((4S)-5,7-Difluoro-3,4-dihydro-2H-chromen-4-yl)oxy)-N,N,2-trimethyl-1H-benzimidazole-5-carboxamide (S)-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo(d)imidazole-6-carboxamide HK inno.N/RaQualia Pharma Alternative Names: CJ-12420; IN-A001; K-CAB; LXI-15028; RQ-00000004; RQ-4 Тегопразан [Russian] [INN] تيغوبرازان [Arabic] [INN] 替戈拉生 [Chinese] [INN] A novel Potassium-competitive acid blocker. OriginatorPfizer Tegoprazan, a reversible H+/K+-ATPase inhibitor developed by CJ Healthcare (now inno.N), was first approved and …